Valeant will pay $96.25 million, or 33 percent of $290 million total litigation settlement reached by Allergan's shareholders and the company + Bill Ackman's Pershing Square over insider trading claims



http://crweworld.com/article/news-provided-by-pr-newswire/201604/valeant-announces-preliminary-resolution-of-allergan-shareholder-securities-litigation



Finish reading with a 14 day trial

or Unlock with your email

Already have an account?
Login here